Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center
Scripps Clinic, Dept. of Endocrinology, Diabetes, and Metabolism
San Diego, CA
Scott Kahan, MD, MPH
Director, National Center for Weight and Wellness
Medical Director, Strategies To Overcome and Prevent (STOP) Obesity Alliance
George Washington University Milken Institute School of Public Health
Chair, Clinical Committee, The Obesity Society
- Describe the impact of excess weight on morbidity and mortality, particularly its effects on metabolic disease and other comorbidities
- Discuss how to address barriers to obesity treatment
- Select at least two barriers to effective management of obesity in the clinical setting and describe strategies to overcome them
- Summarize the current guidelines for obesity management, including lifestyle interventions and pharmacologic therapy
- Identify the components of a multispecialty approach to obesity management.
CONTINUING EDUCATION CREDIT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy and MCM Education. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, staff and reviewers of MCM Education and Purdue University College of Pharmacy have no relationships to disclose.
Dr. Fujioka discloses the following:
Consultant: Amgen, Boehringer-Ingelheim, Eisai, Gelesis, Janssen Global Services, KVK-tech, Novo Nordisk, Sunovion
Grants/research support: Eisai
Speakers bureau: Novo Nordisk
Dr. Kahan discloses the following:
Consultant: Amgen, Bausch, Biologix, Novo Nordisk, Orexigen, Vivus
Purdue University requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is supported by an educational grant from Novo Nordisk Inc.
COURSE VIEWING REQUIREMENTS
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above